Literature DB >> 20952761

MicroRNA expression profile of MCF-7 human breast cancer cells and the effect of green tea polyphenon-60.

Lindsey N Fix1, Maitri Shah, Thomas Efferth, Mary A Farwell, Baohong Zhang.   

Abstract

This study reports for the first time the microRNA expression profile of human breast cancer MCF-7 cells and the effect of green tea. Although hundreds of miRNAs have been identified in humans, only a small proportion (25.6%) of miRNAs are expressed in MCF-7 cells. Low concentration treatment with Polyphenon-60 significantly alters the miRNA expression profile in MCF-7 cells. Twenty three miRNAs have been identified with differential expression after a 48 h treatment with 10 μg/ml Polyphenon-60 (green tea extract). These miRNAs include miR-21 and miR-27 that were found to be down-regulated following treatment with green tea. These two miRNAs have previously been identified as being overexpressed in MCF-7 breast cancer cells, with miR-21 specifically implicated in down-regulating the tumor suppressor gene, tropomyosin-1. This data supports the hypothesis that Polyphenon-60-induced modification of the breast cancer miRNA expression profile contributes to the efficacy of green tea treatment. The resulting decrease in carcinogenesis is further supported by the altered miRNA regulation of potential oncogenes and tumor-suppressor genes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20952761

Source DB:  PubMed          Journal:  Cancer Genomics Proteomics        ISSN: 1109-6535            Impact factor:   4.069


  38 in total

1.  Breast Cancer-Specific miR Signature Unique to Extracellular Vesicles Includes "microRNA-like" tRNA Fragments.

Authors:  Nicole Guzman; Kitty Agarwal; Dilip Asthagiri; Lianbo Yu; Motoyasu Saji; Matthew D Ringel; Michael E Paulaitis
Journal:  Mol Cancer Res       Date:  2015-02-26       Impact factor: 5.852

2.  MiRNA-1469 promotes lung cancer cells apoptosis through targeting STAT5a.

Authors:  Chengshan Xu; Ling Zhang; Hengheng Li; Zhihua Liu; Lianning Duan; Chengrong Lu
Journal:  Am J Cancer Res       Date:  2015-02-15       Impact factor: 6.166

3.  A-to-I RNA Editing Up-regulates Human Dihydrofolate Reductase in Breast Cancer.

Authors:  Masataka Nakano; Tatsuki Fukami; Saki Gotoh; Miki Nakajima
Journal:  J Biol Chem       Date:  2017-02-10       Impact factor: 5.157

4.  Identification of Stable Reference Genes for Toxicogenomic and Gene Expression Analysis.

Authors:  Xiaoping Pan; Baohong Zhang
Journal:  Methods Mol Biol       Date:  2021

Review 5.  Green tea compounds in breast cancer prevention and treatment.

Authors:  Min-Jing Li; Yan-Cun Yin; Jiao Wang; Yang-Fu Jiang
Journal:  World J Clin Oncol       Date:  2014-08-10

6.  Inhibition of proliferation of human lung cancer cells by green tea catechins is mediated by upregulation of let-7.

Authors:  Zhiwei Zhong; Zhuo Dong; Lihua Yang; Xiaoqiang Chen; Zhaohui Gong
Journal:  Exp Ther Med       Date:  2012-05-17       Impact factor: 2.447

Review 7.  Perspectives on the recent developments with green tea polyphenols in drug discovery.

Authors:  Feng Li; Yongli Wang; Dapeng Li; Yilun Chen; Xuguang Qiao; Rania Fardous; Ashton Lewandowski; Jinbao Liu; Tak-Hang Chan; Q Ping Dou
Journal:  Expert Opin Drug Discov       Date:  2018-04-24       Impact factor: 6.098

Review 8.  MicroRNAs as targets for dietary and pharmacological inhibitors of mutagenesis and carcinogenesis.

Authors:  Alberto Izzotti; Cristina Cartiglia; Vernon E Steele; Silvio De Flora
Journal:  Mutat Res       Date:  2012-06-07       Impact factor: 2.433

9.  MicroRNA 'signature' during estrogen-mediated mammary carcinogenesis and its reversal by ellagic acid intervention.

Authors:  Radha Munagala; Farrukh Aqil; Manicka V Vadhanam; Ramesh C Gupta
Journal:  Cancer Lett       Date:  2013-06-18       Impact factor: 8.679

Review 10.  Epigenetic modifications by dietary phytochemicals: implications for personalized nutrition.

Authors:  Sharmila Shankar; Dhruv Kumar; Rakesh K Srivastava
Journal:  Pharmacol Ther       Date:  2012-11-16       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.